PKC mu Antikörper (pTyr463)
Kurzübersicht für PKC mu Antikörper (pTyr463) (ABIN1531512)
Target
Alle PKC mu (PRKD1) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 429-478, pTyr463
-
Verwendungszweck
- PKD1 (phospho Tyr463) Antibody
-
Spezifität
- Phospho-PKD1 (Y463) Polyclonal Antibody detects endogenous levels of PKD1 protein only when phosphorylated at Y463.
-
Aufreinigung
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
-
Reinheit
- > 95 %
-
Immunogen
- The antiserum was produced against synthesized peptide derived from human PKD1/PKC mu around the phosphorylation site of Tyr463. AA range:429-478
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- WB 1:500 - 1:2000. IHC 1:100 - 1:300. ELISA: 1:40000.. IF 1:50-200
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- Liquid in PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C/1 year
-
Haltbarkeit
- 12 months
-
-
- PKC mu (PRKD1) (Protein Kinase D1 (PRKD1))
-
Andere Bezeichnung
- PKD1/PKC mu
-
Hintergrund
-
Synonyms: PRKD1, PKD, PKD1, PRKCM, Serine/threonine-protein kinase D1, Protein kinase C mu type, Protein kinase D, nPKC-D1, nPKC-mu
Background: PRKD1 is a serine/threonine kinase that regulates a variety of cellular functions, including membrane receptor signaling, transport at the Golgi, protection from oxidative stress at the mitochondria, gene transcription, and regulation of cell shape, motility, and adhesion (summary by Eiseler et al., 2009 [PubMed 19329994]).[supplied by OMIM, Nov 2010],
Gene Name: PRKD1
Protein Name: Serine/threonine-protein kinase D1
-
Molekulargewicht
- 101 kDa
-
Gen-ID
- 5587
-
OMIM
- 605435
-
UniProt
- Q15139
-
Pathways
- Myometrial Relaxation and Contraction
Target
-